The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review
Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential. Our aim was to compare the diagnostic accuracy of procalcitonin (PCT), C-reactive protein (CRP), procalcitonin combined with C-reactive protein (PCT + CRP) and presepsin...
Saved in:
| Published in | Critical care (London, England) Vol. 22; no. 1; pp. 316 - 9 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
21.11.2018
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential.
Our aim was to compare the diagnostic accuracy of procalcitonin (PCT), C-reactive protein (CRP), procalcitonin combined with C-reactive protein (PCT + CRP) and presepsin in the diagnosis of neonatal sepsis. We searched seven databases to identify studies that met the inclusion criteria. Two independent reviewers performed data extraction. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), area under curve (AUC), and corresponding 95% credible interval (95% CI) were calculated by true positive (TP), false positive (FP), false negative (FN), and true negative (TN) classification using a bivariate regression model in STATA 14.0 software. The pooled sensitivity, specificity, PLR, NLR, DOR, AUC, and corresponding 95% CI were the primary outcomes. Secondary outcomes included the sensitivity and specificity in multiple subgroup analyses.
A total of 28 studies enrolling 2661 patients were included in our meta-analysis. The pooled sensitivity of CRP (0.71 (0.63, 0.78)) was weaker than that of PCT (0.85 (0.79, 0.89)), PCT + CRP (0.91 (0.84, 0.95)) and presepsin (0.94 (0.80, 0.99)) and the pooled NLR of presepsin (0.06 (0.02, 0.23)) and PCT + CRP (0.10 (0.05, 0.19)) were less than CRP (0.33 (0.26, 0.42)), and the AUC for presepsin (0.99 (0.98, 1.00)) was greater than PCT + CRP (0.96 (0.93, 0.97)), CRP (0.85 (0.82, 0.88)) and PCT (0.91 (0.89, 0.94)). The results of the subgroup analysis showed that 0.5-2 ng/mL may be the appropriate cutoff interval for PCT. A cut-off value > 10 mg/L for CRP had high sensitivity and specificity.
The combination of PCT and CRP or presepsin alone improves the accuracy of diagnosis of neonatal sepsis. However, further studies are required to confirm these findings. |
|---|---|
| AbstractList | Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential. Our aim was to compare the diagnostic accuracy of procalcitonin (PCT), C-reactive protein (CRP), procalcitonin combined with C-reactive protein (PCT + CRP) and presepsin in the diagnosis of neonatal sepsis. We searched seven databases to identify studies that met the inclusion criteria. Two independent reviewers performed data extraction. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), area under curve (AUC), and corresponding 95% credible interval (95% CI) were calculated by true positive (TP), false positive (FP), false negative (FN), and true negative (TN) classification using a bivariate regression model in STATA 14.0 software. The pooled sensitivity, specificity, PLR, NLR, DOR, AUC, and corresponding 95% CI were the primary outcomes. Secondary outcomes included the sensitivity and specificity in multiple subgroup analyses. A total of 28 studies enrolling 2661 patients were included in our meta-analysis. The pooled sensitivity of CRP (0.71 (0.63, 0.78)) was weaker than that of PCT (0.85 (0.79, 0.89)), PCT + CRP (0.91 (0.84, 0.95)) and presepsin (0.94 (0.80, 0.99)) and the pooled NLR of presepsin (0.06 (0.02, 0.23)) and PCT + CRP (0.10 (0.05, 0.19)) were less than CRP (0.33 (0.26, 0.42)), and the AUC for presepsin (0.99 (0.98, 1.00)) was greater than PCT + CRP (0.96 (0.93, 0.97)), CRP (0.85 (0.82, 0.88)) and PCT (0.91 (0.89, 0.94)). The results of the subgroup analysis showed that 0.5-2 ng/mL may be the appropriate cutoff interval for PCT. A cut-off value > 10 mg/L for CRP had high sensitivity and specificity. The combination of PCT and CRP or presepsin alone improves the accuracy of diagnosis of neonatal sepsis. However, further studies are required to confirm these findings. Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential.BACKGROUNDSepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential.Our aim was to compare the diagnostic accuracy of procalcitonin (PCT), C-reactive protein (CRP), procalcitonin combined with C-reactive protein (PCT + CRP) and presepsin in the diagnosis of neonatal sepsis. We searched seven databases to identify studies that met the inclusion criteria. Two independent reviewers performed data extraction. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), area under curve (AUC), and corresponding 95% credible interval (95% CI) were calculated by true positive (TP), false positive (FP), false negative (FN), and true negative (TN) classification using a bivariate regression model in STATA 14.0 software. The pooled sensitivity, specificity, PLR, NLR, DOR, AUC, and corresponding 95% CI were the primary outcomes. Secondary outcomes included the sensitivity and specificity in multiple subgroup analyses.METHODOur aim was to compare the diagnostic accuracy of procalcitonin (PCT), C-reactive protein (CRP), procalcitonin combined with C-reactive protein (PCT + CRP) and presepsin in the diagnosis of neonatal sepsis. We searched seven databases to identify studies that met the inclusion criteria. Two independent reviewers performed data extraction. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), area under curve (AUC), and corresponding 95% credible interval (95% CI) were calculated by true positive (TP), false positive (FP), false negative (FN), and true negative (TN) classification using a bivariate regression model in STATA 14.0 software. The pooled sensitivity, specificity, PLR, NLR, DOR, AUC, and corresponding 95% CI were the primary outcomes. Secondary outcomes included the sensitivity and specificity in multiple subgroup analyses.A total of 28 studies enrolling 2661 patients were included in our meta-analysis. The pooled sensitivity of CRP (0.71 (0.63, 0.78)) was weaker than that of PCT (0.85 (0.79, 0.89)), PCT + CRP (0.91 (0.84, 0.95)) and presepsin (0.94 (0.80, 0.99)) and the pooled NLR of presepsin (0.06 (0.02, 0.23)) and PCT + CRP (0.10 (0.05, 0.19)) were less than CRP (0.33 (0.26, 0.42)), and the AUC for presepsin (0.99 (0.98, 1.00)) was greater than PCT + CRP (0.96 (0.93, 0.97)), CRP (0.85 (0.82, 0.88)) and PCT (0.91 (0.89, 0.94)). The results of the subgroup analysis showed that 0.5-2 ng/mL may be the appropriate cutoff interval for PCT. A cut-off value > 10 mg/L for CRP had high sensitivity and specificity.RESULTSA total of 28 studies enrolling 2661 patients were included in our meta-analysis. The pooled sensitivity of CRP (0.71 (0.63, 0.78)) was weaker than that of PCT (0.85 (0.79, 0.89)), PCT + CRP (0.91 (0.84, 0.95)) and presepsin (0.94 (0.80, 0.99)) and the pooled NLR of presepsin (0.06 (0.02, 0.23)) and PCT + CRP (0.10 (0.05, 0.19)) were less than CRP (0.33 (0.26, 0.42)), and the AUC for presepsin (0.99 (0.98, 1.00)) was greater than PCT + CRP (0.96 (0.93, 0.97)), CRP (0.85 (0.82, 0.88)) and PCT (0.91 (0.89, 0.94)). The results of the subgroup analysis showed that 0.5-2 ng/mL may be the appropriate cutoff interval for PCT. A cut-off value > 10 mg/L for CRP had high sensitivity and specificity.The combination of PCT and CRP or presepsin alone improves the accuracy of diagnosis of neonatal sepsis. However, further studies are required to confirm these findings.CONCLUSIONSThe combination of PCT and CRP or presepsin alone improves the accuracy of diagnosis of neonatal sepsis. However, further studies are required to confirm these findings. Background Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential. Method Our aim was to compare the diagnostic accuracy of procalcitonin (PCT), C-reactive protein (CRP), procalcitonin combined with C-reactive protein (PCT + CRP) and presepsin in the diagnosis of neonatal sepsis. We searched seven databases to identify studies that met the inclusion criteria. Two independent reviewers performed data extraction. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), area under curve (AUC), and corresponding 95% credible interval (95% CI) were calculated by true positive (TP), false positive (FP), false negative (FN), and true negative (TN) classification using a bivariate regression model in STATA 14.0 software. The pooled sensitivity, specificity, PLR, NLR, DOR, AUC, and corresponding 95% CI were the primary outcomes. Secondary outcomes included the sensitivity and specificity in multiple subgroup analyses. Results A total of 28 studies enrolling 2661 patients were included in our meta-analysis. The pooled sensitivity of CRP (0.71 (0.63, 0.78)) was weaker than that of PCT (0.85 (0.79, 0.89)), PCT + CRP (0.91 (0.84, 0.95)) and presepsin (0.94 (0.80, 0.99)) and the pooled NLR of presepsin (0.06 (0.02, 0.23)) and PCT + CRP (0.10 (0.05, 0.19)) were less than CRP (0.33 (0.26, 0.42)), and the AUC for presepsin (0.99 (0.98, 1.00)) was greater than PCT + CRP (0.96 (0.93, 0.97)), CRP (0.85 (0.82, 0.88)) and PCT (0.91 (0.89, 0.94)). The results of the subgroup analysis showed that 0.5-2 ng/mL may be the appropriate cutoff interval for PCT. A cut-off value > 10 mg/L for CRP had high sensitivity and specificity. Conclusions The combination of PCT and CRP or presepsin alone improves the accuracy of diagnosis of neonatal sepsis. However, further studies are required to confirm these findings. Keywords: Meta-analysis, Systematic review, Procalcitonin, C-reactive protein, Neonatal sepsis Background Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential. Method Our aim was to compare the diagnostic accuracy of procalcitonin (PCT), C-reactive protein (CRP), procalcitonin combined with C-reactive protein (PCT + CRP) and presepsin in the diagnosis of neonatal sepsis. We searched seven databases to identify studies that met the inclusion criteria. Two independent reviewers performed data extraction. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), area under curve (AUC), and corresponding 95% credible interval (95% CI) were calculated by true positive (TP), false positive (FP), false negative (FN), and true negative (TN) classification using a bivariate regression model in STATA 14.0 software. The pooled sensitivity, specificity, PLR, NLR, DOR, AUC, and corresponding 95% CI were the primary outcomes. Secondary outcomes included the sensitivity and specificity in multiple subgroup analyses. Results A total of 28 studies enrolling 2661 patients were included in our meta-analysis. The pooled sensitivity of CRP (0.71 (0.63, 0.78)) was weaker than that of PCT (0.85 (0.79, 0.89)), PCT + CRP (0.91 (0.84, 0.95)) and presepsin (0.94 (0.80, 0.99)) and the pooled NLR of presepsin (0.06 (0.02, 0.23)) and PCT + CRP (0.10 (0.05, 0.19)) were less than CRP (0.33 (0.26, 0.42)), and the AUC for presepsin (0.99 (0.98, 1.00)) was greater than PCT + CRP (0.96 (0.93, 0.97)), CRP (0.85 (0.82, 0.88)) and PCT (0.91 (0.89, 0.94)). The results of the subgroup analysis showed that 0.5–2 ng/mL may be the appropriate cutoff interval for PCT. A cut-off value > 10 mg/L for CRP had high sensitivity and specificity. Conclusions The combination of PCT and CRP or presepsin alone improves the accuracy of diagnosis of neonatal sepsis. However, further studies are required to confirm these findings. Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential. Our aim was to compare the diagnostic accuracy of procalcitonin (PCT), C-reactive protein (CRP), procalcitonin combined with C-reactive protein (PCT + CRP) and presepsin in the diagnosis of neonatal sepsis. We searched seven databases to identify studies that met the inclusion criteria. Two independent reviewers performed data extraction. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), area under curve (AUC), and corresponding 95% credible interval (95% CI) were calculated by true positive (TP), false positive (FP), false negative (FN), and true negative (TN) classification using a bivariate regression model in STATA 14.0 software. The pooled sensitivity, specificity, PLR, NLR, DOR, AUC, and corresponding 95% CI were the primary outcomes. Secondary outcomes included the sensitivity and specificity in multiple subgroup analyses. A total of 28 studies enrolling 2661 patients were included in our meta-analysis. The pooled sensitivity of CRP (0.71 (0.63, 0.78)) was weaker than that of PCT (0.85 (0.79, 0.89)), PCT + CRP (0.91 (0.84, 0.95)) and presepsin (0.94 (0.80, 0.99)) and the pooled NLR of presepsin (0.06 (0.02, 0.23)) and PCT + CRP (0.10 (0.05, 0.19)) were less than CRP (0.33 (0.26, 0.42)), and the AUC for presepsin (0.99 (0.98, 1.00)) was greater than PCT + CRP (0.96 (0.93, 0.97)), CRP (0.85 (0.82, 0.88)) and PCT (0.91 (0.89, 0.94)). The results of the subgroup analysis showed that 0.5-2 ng/mL may be the appropriate cutoff interval for PCT. A cut-off value > 10 mg/L for CRP had high sensitivity and specificity. The combination of PCT and CRP or presepsin alone improves the accuracy of diagnosis of neonatal sepsis. However, further studies are required to confirm these findings. Abstract Background Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential. Method Our aim was to compare the diagnostic accuracy of procalcitonin (PCT), C-reactive protein (CRP), procalcitonin combined with C-reactive protein (PCT + CRP) and presepsin in the diagnosis of neonatal sepsis. We searched seven databases to identify studies that met the inclusion criteria. Two independent reviewers performed data extraction. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), area under curve (AUC), and corresponding 95% credible interval (95% CI) were calculated by true positive (TP), false positive (FP), false negative (FN), and true negative (TN) classification using a bivariate regression model in STATA 14.0 software. The pooled sensitivity, specificity, PLR, NLR, DOR, AUC, and corresponding 95% CI were the primary outcomes. Secondary outcomes included the sensitivity and specificity in multiple subgroup analyses. Results A total of 28 studies enrolling 2661 patients were included in our meta-analysis. The pooled sensitivity of CRP (0.71 (0.63, 0.78)) was weaker than that of PCT (0.85 (0.79, 0.89)), PCT + CRP (0.91 (0.84, 0.95)) and presepsin (0.94 (0.80, 0.99)) and the pooled NLR of presepsin (0.06 (0.02, 0.23)) and PCT + CRP (0.10 (0.05, 0.19)) were less than CRP (0.33 (0.26, 0.42)), and the AUC for presepsin (0.99 (0.98, 1.00)) was greater than PCT + CRP (0.96 (0.93, 0.97)), CRP (0.85 (0.82, 0.88)) and PCT (0.91 (0.89, 0.94)). The results of the subgroup analysis showed that 0.5–2 ng/mL may be the appropriate cutoff interval for PCT. A cut-off value > 10 mg/L for CRP had high sensitivity and specificity. Conclusions The combination of PCT and CRP or presepsin alone improves the accuracy of diagnosis of neonatal sepsis. However, further studies are required to confirm these findings. |
| ArticleNumber | 316 |
| Audience | Academic |
| Author | Li, Shu-Fang Tao, Zheng Li, Chun-Ni Zhao, Yun Xu, Guang-Yu Liu, Zhen Chen, Lin-Shan Chen, Guan-Yu Ruan, Lin |
| Author_xml | – sequence: 1 givenname: Lin surname: Ruan fullname: Ruan, Lin – sequence: 2 givenname: Guan-Yu surname: Chen fullname: Chen, Guan-Yu – sequence: 3 givenname: Zhen surname: Liu fullname: Liu, Zhen – sequence: 4 givenname: Yun surname: Zhao fullname: Zhao, Yun – sequence: 5 givenname: Guang-Yu surname: Xu fullname: Xu, Guang-Yu – sequence: 6 givenname: Shu-Fang surname: Li fullname: Li, Shu-Fang – sequence: 7 givenname: Chun-Ni surname: Li fullname: Li, Chun-Ni – sequence: 8 givenname: Lin-Shan surname: Chen fullname: Chen, Lin-Shan – sequence: 9 givenname: Zheng surname: Tao fullname: Tao, Zheng |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30463590$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1v1DAQhiNURD_gB3BBkbhwSfFH7I05IFUrPipV4rJ3a-JMtq4Se7GzW-0v4m8y6ZbSVgjlEHv8zDsz9ntaHIUYsCjecnbOeaM_Zi6ZqivGm0oIqSv-ojjhUtdVo6Q6erQ-Lk5zvmGMLxotXxXHktVaKsNOil-rayxdHFsfYPIxlLEvNyk6GJyfYvChhNCVyyohuMnvcD6ckMIx0RIzbvLMDNRY6Uc63GEuJ9IE57YJ3H4W7DysQ8w-z5uAkUrBUN7l5k8llCNOUEGAYT8zc8G8zxOO1JErE-483r4uXvYwZHxz_z8rVl-_rJbfq6sf3y6XF1eVU5pNVSOBq37RtwI7IyW2teOmF7phzECtjBMKDXQA2LaOayNQIdMCXCeV6Jw8Ky4Psl2EG7tJfoS0txG8vQvEtLaQqKsBrRMtMiEXphZNbVpoqNiiFkrrznVtp0nr80Frs21H7ByGKcHwRPTpSfDXdh13VovaGC5I4MO9QIo_t5gnO_rscBiA7nCbreCSnrPmhhP6_hl6E7eJbpQoVSvNuVqYv9QaaAAf-kh13SxqLxTdUS05k0Sd_4Oir8PRO3ro3lP8ScK7x4M-TPjHZQTwA-BSzDlh_4BwZmcn24OTLTnZzk6280SLZzlkyDuLUjd--E_mb5A7-i0 |
| CitedBy_id | crossref_primary_10_56294_saludcyt20241294 crossref_primary_10_1097_MD_0000000000034953 crossref_primary_10_1080_14767058_2023_2205986 crossref_primary_10_18499_1990_472X_2023_1_91_66_72 crossref_primary_10_1186_s12879_025_10821_w crossref_primary_10_1016_j_amjsurg_2023_11_024 crossref_primary_10_51620_0869_2084_2022_67_1_13_18 crossref_primary_10_3390_biom15010123 crossref_primary_10_1016_j_cca_2023_117387 crossref_primary_10_1155_2020_8889086 crossref_primary_10_1177_03000605241247696 crossref_primary_10_3390_diagnostics15020213 crossref_primary_10_1080_14787210_2019_1584037 crossref_primary_10_1186_s12879_021_06636_0 crossref_primary_10_1016_j_cyto_2020_155000 crossref_primary_10_1097_INF_0000000000002682 crossref_primary_10_3389_fcimb_2023_1286313 crossref_primary_10_3389_fcimb_2022_1045636 crossref_primary_10_3390_antibiotics10050580 crossref_primary_10_1002_acn3_51356 crossref_primary_10_1021_acsabm_4c01230 crossref_primary_10_1097_PCC_0000000000002734 crossref_primary_10_1186_s12887_022_03285_3 crossref_primary_10_1007_s11908_021_00765_y crossref_primary_10_1038_s41390_021_01696_z crossref_primary_10_1515_biol_2022_1005 crossref_primary_10_1097_MD_0000000000025706 crossref_primary_10_12688_f1000research_131669_1 crossref_primary_10_5847_wjem_j_1920_8642_2024_028 crossref_primary_10_1097_INF_0000000000003344 crossref_primary_10_1097_MD_0000000000026555 crossref_primary_10_1155_2021_1009231 crossref_primary_10_1371_journal_pone_0250101 crossref_primary_10_1097_SHK_0000000000001870 crossref_primary_10_1016_j_clim_2023_109690 crossref_primary_10_1155_2020_7280708 crossref_primary_10_11569_wcjd_v29_i14_825 crossref_primary_10_1016_j_ajem_2019_05_001 crossref_primary_10_3390_ijerph18030882 crossref_primary_10_1055_a_2086_3201 crossref_primary_10_3389_fped_2021_740274 crossref_primary_10_1016_j_jss_2023_03_045 crossref_primary_10_1093_jac_dkae067 crossref_primary_10_1055_s_0042_1758479 crossref_primary_10_1093_jpids_piab066 crossref_primary_10_1093_jpids_piab068 crossref_primary_10_1097_MD_0000000000036724 crossref_primary_10_1590_1414_431x2020e10603 crossref_primary_10_3390_jcm13237038 crossref_primary_10_3390_antibiotics12020352 crossref_primary_10_5604_01_3001_0016_0233 crossref_primary_10_7759_cureus_28319 crossref_primary_10_1177_00099228231199001 crossref_primary_10_3390_children7120309 crossref_primary_10_3233_NPM_200581 crossref_primary_10_3390_antibiotics14010006 crossref_primary_10_3390_antibiotics12040695 crossref_primary_10_22141_2224_0551_18_2_2023_1573 crossref_primary_10_3389_fimmu_2023_1000431 crossref_primary_10_1007_s12603_022_1761_4 crossref_primary_10_1155_2021_3432010 crossref_primary_10_12677_ACM_2024_141237 crossref_primary_10_3390_children9081171 crossref_primary_10_1093_cid_ciaa876 crossref_primary_10_1155_2022_2498435 crossref_primary_10_1016_j_arcped_2022_01_013 crossref_primary_10_1186_s40001_024_01984_4 crossref_primary_10_17235_reed_2020_6591_2019 crossref_primary_10_3389_fimmu_2019_01363 crossref_primary_10_3389_fimmu_2020_572634 crossref_primary_10_1097_JCMA_0000000000000681 crossref_primary_10_2147_TCRM_S291242 crossref_primary_10_21673_anadoluklin_975177 crossref_primary_10_1001_jamapediatrics_2022_1647 crossref_primary_10_1097_CCM_0000000000005711 crossref_primary_10_1016_j_cca_2023_117588 crossref_primary_10_1038_s41598_022_16744_9 crossref_primary_10_1097_SHK_0000000000002380 crossref_primary_10_1371_journal_pone_0224880 crossref_primary_10_1080_0886022X_2021_2021236 crossref_primary_10_1111_jocs_15952 crossref_primary_10_1186_s12893_021_01345_6 crossref_primary_10_1111_vcp_13238 crossref_primary_10_2147_JIR_S414611 crossref_primary_10_1515_cclm_2022_0801 crossref_primary_10_3390_jcm9010127 crossref_primary_10_3389_fimmu_2021_631308 crossref_primary_10_3390_medicina57080770 crossref_primary_10_7759_cureus_30211 crossref_primary_10_1002_hsr2_1229 crossref_primary_10_12688_f1000research_132099_1 crossref_primary_10_21292_2078_5658_2020_17_6_72_79 crossref_primary_10_12688_f1000research_132099_2 crossref_primary_10_1177_1721727X221144392 crossref_primary_10_1177_08850666231214243 crossref_primary_10_1186_s12913_024_11811_5 crossref_primary_10_12677_ACM_2023_134752 crossref_primary_10_1093_jleuko_qiae121 crossref_primary_10_12677_acm_2024_1441063 crossref_primary_10_12998_wjcc_v9_i25_7405 crossref_primary_10_3389_fped_2022_1019825 crossref_primary_10_1038_s41598_021_01556_0 crossref_primary_10_1631_jzus_B2200285 crossref_primary_10_1111_bjh_19009 crossref_primary_10_3390_molecules29081717 crossref_primary_10_1136_bmjpo_2022_001627 crossref_primary_10_1186_s12890_020_01207_6 crossref_primary_10_1016_j_cmi_2023_02_021 crossref_primary_10_2147_JIR_S334642 crossref_primary_10_1007_s15010_024_02354_2 crossref_primary_10_1016_j_ijantimicag_2019_07_016 crossref_primary_10_1097_PCC_0000000000002453 crossref_primary_10_1080_00365513_2024_2346914 crossref_primary_10_1186_s12985_021_01502_6 crossref_primary_10_3390_ijms222212154 crossref_primary_10_1371_journal_pone_0301859 crossref_primary_10_1093_jac_dkad177 crossref_primary_10_26693_jmbs05_02_029 crossref_primary_10_1016_j_cyto_2022_155911 crossref_primary_10_1093_jalm_jfad007 crossref_primary_10_12788_jhm_3451 crossref_primary_10_1016_j_cegh_2025_101957 crossref_primary_10_1128_JCM_01851_19 crossref_primary_10_7759_cureus_19485 crossref_primary_10_3390_children11030350 crossref_primary_10_1186_s12879_023_08851_3 crossref_primary_10_1038_s41390_022_02190_w crossref_primary_10_1007_s12519_022_00635_0 crossref_primary_10_17816_PED626896 crossref_primary_10_23736_S2724_5276_21_06149_1 crossref_primary_10_3390_children11010124 crossref_primary_10_7759_cureus_62230 |
| Cites_doi | 10.1373/clinchem.2003.025171 10.1016/j.jaut.2011.12.003 10.1542/peds.2014-1755 10.1007/s12098-018-2659-3 10.21474/IJAR01/716 10.1001/jama.292.19.2357 10.1016/S1473-3099(04)01146-6 10.3329/bmrcb.v37i2.8432 10.1038/pr.2016.217 10.1007/s00134-011-2174-8 10.1097/00003246-199903000-00024 10.1007/s001340000709 10.1038/jp.2008.207 10.1055/s-0036-1593851 10.1186/s12879-017-2396-7 10.4084/mjhid.2012.028 10.1016/S0140-6736(09)61879-1 10.1097/01.PCC.0000149131.72248.E6 10.1136/adc.2008.155754 10.1080/00365540210147723 10.1067/S0196-0644(03)00628-0 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2018 BioMed Central Ltd. 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2018 |
| Copyright_xml | – notice: COPYRIGHT 2018 BioMed Central Ltd. – notice: 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2018 |
| DBID | AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s13054-018-2236-1 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1364-8535 1466-609X 1366-609X |
| EndPage | 9 |
| ExternalDocumentID | oai_doaj_org_article_c2be0237942849ba8eb4742566dcdbd6 PMC6249912 A568043103 30463590 10_1186_s13054_018_2236_1 |
| Genre | Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | --- 0R~ 29F 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABUWG ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EBD EBLON EBS EJD EMOBN F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P OK1 PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SJN SMD SOJ SV3 TR2 U2A UKHRP WOQ YOC -5E -5G -BR 3V. ACRMQ ADINQ C24 NPM PMFND 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c560t-83a15f7fb2ed933eb4c19f268009a459c25e9adaaebbc1692e5e062acd352dc3 |
| IEDL.DBID | 7X7 |
| ISSN | 1364-8535 1466-609X |
| IngestDate | Wed Aug 27 01:32:11 EDT 2025 Thu Aug 21 13:54:53 EDT 2025 Fri Jul 11 15:22:58 EDT 2025 Fri Jul 25 21:09:06 EDT 2025 Tue Jun 17 21:06:19 EDT 2025 Tue Jun 10 20:32:17 EDT 2025 Wed Feb 19 02:34:23 EST 2025 Tue Jul 01 03:54:46 EDT 2025 Thu Apr 24 22:51:41 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Systematic review C-reactive protein Procalcitonin Meta-analysis Neonatal sepsis |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c560t-83a15f7fb2ed933eb4c19f268009a459c25e9adaaebbc1692e5e062acd352dc3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://www.proquest.com/docview/2545611579?pq-origsite=%requestingapplication% |
| PMID | 30463590 |
| PQID | 2545611579 |
| PQPubID | 44362 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_c2be0237942849ba8eb4742566dcdbd6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6249912 proquest_miscellaneous_2138634191 proquest_journals_2545611579 gale_infotracmisc_A568043103 gale_infotracacademiconefile_A568043103 pubmed_primary_30463590 crossref_primary_10_1186_s13054_018_2236_1 crossref_citationtrail_10_1186_s13054_018_2236_1 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-11-21 |
| PublicationDateYYYYMMDD | 2018-11-21 |
| PublicationDate_xml | – month: 11 year: 2018 text: 2018-11-21 day: 21 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Critical care (London, England) |
| PublicationTitleAlternate | Crit Care |
| PublicationYear | 2018 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | AA Ozdemir (2236_CR20) 2017; 34 H Ugarte (2236_CR4) 1999; 27 BJ Stoll (2236_CR2) 2004; 292 P Montaldo (2236_CR18) 2017; 81 NY Boo (2236_CR3) 2008; 49 M Çetinkaya (2236_CR8) 2009; 29 TL Geurs (2236_CR14) 2012; 38 S Topcuoglu (2236_CR21) 2016; 29 P Schuetz (2236_CR16) 2009; 139 C Poggi (2236_CR17) 2015; 135 A Jacquot (2236_CR24) 2009; 94 AMC van Rossum (2236_CR9) 2004; 4 MA Mannan (2236_CR15) 2010; 19 American College of Emergency Physicians Clinical Policies Committee; American College of Emergency Physicians Clinical Policies Subcommittee on Pediatric Fever (2236_CR5) 2003; 42 A Abdollahi (2236_CR7) 2012; 4 EK Vouloumanou (2236_CR12) 2011; 37 J Sabry (2236_CR19) 2016; 4 BS Naher (2236_CR13) 2011; 37 G Pontrelli (2236_CR23) 2017; 17 B Goldstein (2236_CR11) 2005; 6 A Enguix (2236_CR27) 2001; 27 L Bouadma (2236_CR6) 2010; 375 P Dandona (2236_CR10) 1994; 79 J Blommendahl (2236_CR25) 2002; 34 L Shen (2236_CR26) 2012; 25 C Chiesa (2236_CR1) 2004; 50 2236_CR22 |
| References_xml | – volume: 50 start-page: 279 issue: 2 year: 2004 ident: 2236_CR1 publication-title: Clin Chem doi: 10.1373/clinchem.2003.025171 – volume: 38 start-page: J245 issue: 2–3 year: 2012 ident: 2236_CR14 publication-title: J Autoimmun doi: 10.1016/j.jaut.2011.12.003 – volume: 49 start-page: 204 issue: 3 year: 2008 ident: 2236_CR3 publication-title: Singap Med J – volume: 135 start-page: 68 issue: 1 year: 2015 ident: 2236_CR17 publication-title: Pediatrics doi: 10.1542/peds.2014-1755 – ident: 2236_CR22 doi: 10.1007/s12098-018-2659-3 – volume: 4 start-page: 1538 issue: 6 year: 2016 ident: 2236_CR19 publication-title: Int J Adv Res doi: 10.21474/IJAR01/716 – volume: 292 start-page: 2357 issue: 19 year: 2004 ident: 2236_CR2 publication-title: Jama doi: 10.1001/jama.292.19.2357 – volume: 29 start-page: 1834 issue: 11 year: 2016 ident: 2236_CR21 publication-title: J Matern Fetal Neonatal Med – volume: 79 start-page: 1605 issue: 6 year: 1994 ident: 2236_CR10 publication-title: J Clin Endocrinol Metab – volume: 4 start-page: 620 issue: 10 year: 2004 ident: 2236_CR9 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(04)01146-6 – volume: 37 start-page: 40 issue: 2 year: 2011 ident: 2236_CR13 publication-title: Bangladesh Med Res Counc Bull doi: 10.3329/bmrcb.v37i2.8432 – volume: 139 start-page: 318 issue: 23–24 year: 2009 ident: 2236_CR16 publication-title: Swiss Med Wkly – volume: 81 start-page: 329 issue: 2 year: 2017 ident: 2236_CR18 publication-title: Pediatr Res doi: 10.1038/pr.2016.217 – volume: 19 start-page: 259 issue: 2 year: 2010 ident: 2236_CR15 publication-title: Mymensingh Med J – volume: 25 start-page: 995 issue: 10 year: 2012 ident: 2236_CR26 publication-title: Chin J Clin Res – volume: 37 start-page: 747 issue: 5 year: 2011 ident: 2236_CR12 publication-title: Intensive Care Med doi: 10.1007/s00134-011-2174-8 – volume: 27 start-page: 498 issue: 3 year: 1999 ident: 2236_CR4 publication-title: Crit Care Med doi: 10.1097/00003246-199903000-00024 – volume: 27 start-page: 211 issue: 1 year: 2001 ident: 2236_CR27 publication-title: Intensive Care Med doi: 10.1007/s001340000709 – volume: 29 start-page: 225 issue: 3 year: 2009 ident: 2236_CR8 publication-title: J Perinatol doi: 10.1038/jp.2008.207 – volume: 34 start-page: 550 issue: 6 year: 2017 ident: 2236_CR20 publication-title: Am J Perinatol doi: 10.1055/s-0036-1593851 – volume: 17 start-page: 302 issue: 1 year: 2017 ident: 2236_CR23 publication-title: BMC Infect Dis doi: 10.1186/s12879-017-2396-7 – volume: 4 start-page: e2012028 issue: 1 year: 2012 ident: 2236_CR7 publication-title: Mediterr J Hematol Infect Dis doi: 10.4084/mjhid.2012.028 – volume: 375 start-page: 463 issue: 9713 year: 2010 ident: 2236_CR6 publication-title: Lancet (London, England) doi: 10.1016/S0140-6736(09)61879-1 – volume: 6 start-page: 2 issue: 1 year: 2005 ident: 2236_CR11 publication-title: Pediatr Crit Care Med doi: 10.1097/01.PCC.0000149131.72248.E6 – volume: 94 start-page: F345 issue: 5 year: 2009 ident: 2236_CR24 publication-title: Arch Dis Child Fetal Neonatal Ed doi: 10.1136/adc.2008.155754 – volume: 34 start-page: 620 issue: 8 year: 2002 ident: 2236_CR25 publication-title: Scand J Infect Dis doi: 10.1080/00365540210147723 – volume: 42 start-page: 530 issue: 4 year: 2003 ident: 2236_CR5 publication-title: Ann Emerg Med doi: 10.1067/S0196-0644(03)00628-0 |
| SSID | ssj0017863 |
| Score | 2.582374 |
| Snippet | Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential.
Our aim was to compare the... Background Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential. Method Our aim was... Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential. Our aim was to compare the... Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential.BACKGROUNDSepsis is an... Abstract Background Sepsis is an important cause of neonatal morbidity and mortality; therefore, the early diagnosis of neonatal sepsis is essential. Method... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 316 |
| SubjectTerms | Accuracy Antibiotics Bacterial infections Bias Biomarkers Blood tests C-reactive protein Critical care Diagnosis Drug resistance Infections Medical diagnosis Meta-analysis Neonatal diseases Neonatal sepsis Newborn babies Patients Procalcitonin Proteins Sepsis Software Systematic review Viral infections |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NixMxGA6yB_Eirp_jrhJBEISwTWYmTbyti8sirKcV9hbyNVio06XTHvxF_k2fZNLaQdCLx84kaZL3yfsxefOEkLdaitApJxCbqIY1tXBMWceZ8g6BWISB4Ons8PUXefW1-Xzb3h5c9ZVywkZ64HHizrxwEXYFsIEi1c6q6Bq0Ai8k-OBCJtuGzdsFU2X_YK5kXfYwuZJnAzR1m7ItgApRS8YnViiT9f-pkg9s0jRf8sAAXT4iD4vnSM_HHh-Te7F_TO5fl73xJ-QnJE6BH4S6ebbpqqPJPNmlx6rtFz21faAXDF5i1nE0UzTg8WpNUzZsvBtSmeWqj3SRPzXEgcI9pNb77dr6H6nBMGbmLYb0o4_p0zv6lOsOH6il3-PGMluITvIf_qaKpuMxmafk5vLTzcUVK9cwMA93aMNUbXnbzTsnYtB1jfn3XHdCwtXUtmm1F23UNlgbnfNcahHbOJPC-gDnLvj6GTnq0fUXhEL-nYt15zqFKCwIp7xqRKe9knKGZioy20nF-EJRnm7KWJocqihpRkEaCNIkQRpekff7KncjP8ffCn9Mot4XTNTa-QEAZwrgzL8AV5F3CSgmKQB0zttyjgFDTFRa5rzFzDTp-raKnE5KYuH66esd1ExRHIMR2aPl7VxX5M3-daqZkuEg1y3K8BrwbhBpV-T5iMz9kDIDXKtnFZlPMDsZ8_RNv_iWacUlInHNxcv_MUkn5IFIq41zJvgpOdqst_EVvLeNe50X6i-9b0TJ priority: 102 providerName: Directory of Open Access Journals |
| Title | The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30463590 https://www.proquest.com/docview/2545611579 https://www.proquest.com/docview/2138634191 https://pubmed.ncbi.nlm.nih.gov/PMC6249912 https://doaj.org/article/c2be0237942849ba8eb4742566dcdbd6 |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdbC2MvY9_z1hUNBoOBaCTbirSX0ZSWMmgZpYOwF6Evb4HMyeLkYX_R_s3dyUpaM-iLwZZkS77TfUin3xHyXksRGuUE-CaqYlUpHFPWcaa8A0csgoLgeHb44lKef6u-TOtpXnDrcljlViYmQR0WHtfIj0RS9bwe68_L3wyzRuHuak6hcZ_sI3QZhnSNpzuHi49VyqTGS1kx-GqddzW5kkcdyO4a4y-AT0QpGR_opQTf_7-QvqWlhhGUt1TS2WPyKNuS9Lgn_hNyL7ZPyYOLvFv-jPwFHqAwOnB-0_-ni4aiwrJzD_O4nbXUtoGeMLAbk9SjCbQBHi9WFONj47LDOvNFG-ksLT7EjoLBSK33m5X1f_CFoY_Vm3V400ZcjIc-pbbdJ2rpr7i2zGbok_TBG_Bo2h-ceU6uz06vT85ZTszAPBhIa6ZKy-tm3DgRgy7L6CrPdSMkGJ_aVrX2oo7aBmujc55LLWIdR1JYH8DcC758QfZa6PorQoEjGhfLxjUK_LIgnPKqEo32SsoRvKYgoy1VjM-g5Zg7Y26S86Kk6QlpgJAGCWl4QT7umix7xI67Kk-Q1LuKCLadHixWP0yeu8YLF8G0AckFulw7q2DAwMhgCAcfXJAF-YCMYlAkQOe8zScbYIgIrmWOa_gzFSZ0K8jBoCZMZT8s3rKayaKkMzeMX5B3u2JsieFxQNcN1OElsHoFvndBXvacuRtSwoSr9agg4wHPDsY8LGlnPxPQuATfXHPx-u5uvSEPBc4jzpngB2RvvdrEt2Cprd1hmo6HZH9yevn16jCtd8D1avL9H_6bQa0 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1daxQxMNQrqC_it6tVIyiCEHrJ7uaygkhbW662d4ic0LeQr9WDuldv75D-Ip_8j85k965dhL71cTeTbGZnMh_JZIaQ14UUvlRWgG-iMpalwjJlLGfKWXDEAigIjneHR2M5_JZ9PslPNsjf1V0YDKtcycQoqP3M4R75toiqnueD4uPZL4ZVo_B0dVVCo2GLo3D-G1y2-sPhJ6DvGyEO9id7Q9ZWFWAOtPuCqdTwvByUVgQP3nywmeNFKSRYToXJ8sKJPBTGGxOsdVwWIuShL4VxHmwV71IY9gbZzFLwZHpkc3d__OXr-thioGLpNp7KjAGaeXuMypXcrkFZ5BjwAYwpUsl4RxHGegH_a4VLarEbsnlJBx7cJXda45XuNNx2j2yE6j65OWqP5x-QP8B0FH4neNuR4HRWUtSQ5tSB4KimFTWVp3sMDNUoZmnMEgGvZ3OKAbnhrEaY01kV6DTudoSagoVKjXPLuXHnOKBvggOnNT5UAXf_YU6xb_2eGvozLAwzba6V-MGLbNW0uanzkEyug2aPSK-CqT8hFFiwtCEtbanAEfTCKqcyURZOSdmHYRLSX1FFuzZLOhbrONXRW1JSN4TUQEiNhNQ8Ie_WXc6aFCFXAe8iqdeAmN07vpjNv-tWWGgnbABbCkQlGA-FNQoQhpUDlrd33nqZkLfIKBplEEzOmfYqBaCI2bz0Tg5_JsMKcgnZ6kCC7HDd5hWr6VZ21fpipSXk1boZe2I8HtB1CTA8BVbPwNlPyOOGM9coxSR0edFPyKDDsx2cuy3V9EfMbC4FOOBcPL16Wi_JreFkdKyPD8dHz8htgWuKcyb4Fukt5svwHMzEhX3RLk5K9DWLg3_G9n0W |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+combination+of+procalcitonin+and+C-reactive+protein+or+presepsin+alone+improves+the+accuracy+of+diagnosis+of+neonatal+sepsis%3A+a+meta-analysis+and+systematic+review&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Ruan%2C+Lin&rft.au=Chen%2C+Guan-Yu&rft.au=Liu%2C+Zhen&rft.au=Zhao%2C+Yun&rft.date=2018-11-21&rft.pub=BioMed+Central+Ltd&rft.issn=1364-8535&rft.volume=22&rft.issue=1&rft_id=info:doi/10.1186%2Fs13054-018-2236-1&rft.externalDocID=A568043103 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon |